Roger J. Pomerantz is a businessperson who has been at the helm of 14 different companies.
He occupies the position of Independent Chairman for CollPlant Biotechnologies Ltd., Chairman at Silicon INSITE, Inc., Chairman of Viracta Therapeutics, Inc., Chairman at Viracta Subsidiary, Inc. (a subsidiary of Viracta Therapeutics, Inc.), Chairman of Indaptus Therapeutics, Inc. and President for Pomerantz Life Sciences Consulting Group LLC.
He is also on the board of X-Vax Technology, Inc.
Roger J. Pomerantz previously was Chairman, President & Chief Executive Officer of ContraFect Corp., Chairman of Seres Therapeutics, Inc., Senior VP & Head-Licensing & Acquisitions at Merck & Co., Inc., Professor at Molecular Pharmacology (USA) Ltd., Senior Partner at Flagship Pioneering, Chairman at Sunesis Pharmaceuticals, Inc., Chairman of Intec Pharma Ltd., Chief Executive Officer for Tibotec Pharmaceuticals, President of Janssen R&D Ireland Ltd., President at Janssen Therapeutics, Inc., Chief Resident at The General Hospital Corp., Global Head-Infectious Diseases at Johnson & Johnson Pharmaceutical Group, Chairman at Institute of Human Virology, Professor at Thomas Jefferson University and Professor at Sidney Kimmel Medical College.
Roger J. Pomerantz received an undergraduate degree from The Johns Hopkins University and a doctorate from The Johns Hopkins University School of Medicine.